Alicja Januszewicz
Directeur/Membre du Conseil chez Women In The Enterprise of Science & Technology
Postes actifs de Alicja Januszewicz
Sociétés | Poste | Début | Fin |
---|---|---|---|
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Alicja Januszewicz
Anciens postes connus de Alicja Januszewicz
Sociétés | Poste | Début | Fin |
---|---|---|---|
THESEUS PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | 16/12/2021 | 01/11/2022 |
BAXTER INTERNATIONAL INC. | Responsable des Ressources Humaines | 01/08/2015 | 01/11/2016 |
EPIZYME, INC. | Corporate Officer/Principal | 01/01/2007 | 01/01/2013 |
ALLENA PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | 01/01/2019 | - |
Formation de Alicja Januszewicz
Kenan-Flagler Business School | Undergraduate Degree |
Polish Academy of Sciences | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Pologne | 2 |
Opérationnelle
Human Resources Officer | 3 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALLENA PHARMACEUTICALS, INC. | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Commercial Services |
- Bourse
- Insiders
- Alicja Januszewicz
- Expérience